Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease.

de Vos LC, Noordzij MJ, Mulder DJ, Smit AJ, Lutgers HL, Dullaart RP, Kamphuisen PW, Zeebregts CJ, Lefrandt JD.

Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):131-8. doi: 10.1161/ATVBAHA.112.300016. Epub 2012 Nov 8.

2.

Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease.

Noordzij MJ, Lefrandt JD, Loeffen EA, Saleem BR, Meerwaldt R, Lutgers HL, Smit AJ, Zeebregts CJ.

Int J Cardiovasc Imaging. 2012 Feb;28(2):431-8. doi: 10.1007/s10554-011-9805-6. Epub 2011 Feb 19.

3.

Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease.

de Vos LC, Mulder DJ, Smit AJ, Dullaart RP, Kleefstra N, Lijfering WM, Kamphuisen PW, Zeebregts CJ, Lefrandt JD.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):933-8. doi: 10.1161/ATVBAHA.113.302731. Epub 2014 Feb 13.

4.

Skin autofluorescence as a measure of advanced glycation end products deposition predicts 5-year amputation in patients with peripheral artery disease.

de Vos LC, Boersema J, Mulder DJ, Smit AJ, Zeebregts CJ, Lefrandt JD.

Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1532-7. doi: 10.1161/ATVBAHA.115.305407. Epub 2015 Apr 16.

PMID:
25882066
5.

Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3.

McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2356-63. doi: 10.2215/CJN.02420311. Epub 2011 Sep 1.

6.

Advanced glycation end products, measured as skin autofluorescence, at diagnosis in gestational diabetes mellitus compared with normal pregnancy.

de Ranitz-Greven WL, Bos DC, Poucki WK, Visser GH, Beulens JW, Biesma DH, de Valk HW.

Diabetes Technol Ther. 2012 Jan;14(1):43-9. doi: 10.1089/dia.2011.0105. Epub 2011 Aug 29.

PMID:
21875328
7.

Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease.

Smit AJ, Gerrits EG.

Curr Opin Nephrol Hypertens. 2010 Nov;19(6):527-33. doi: 10.1097/MNH.0b013e32833e9259. Review.

PMID:
20844429
8.

Skin autofluorescence associates with vascular calcification in chronic kidney disease.

Wang AY, Wong CK, Yau YY, Wong S, Chan IH, Lam CW.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1784-90. doi: 10.1161/ATVBAHA.114.303378. Epub 2014 May 29.

9.

Advanced glycation end products in the skin are enhanced in COPD.

Hoonhorst SJ, Lo Tam Loi AT, Hartman JE, Telenga ED, van den Berge M, Koenderman L, Lammers JW, Boezen HM, Postma DS, Ten Hacken NH.

Metabolism. 2014 Sep;63(9):1149-56. doi: 10.1016/j.metabol.2014.06.006. Epub 2014 Jun 13.

PMID:
25034386
10.

Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.

Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ.

J Am Soc Nephrol. 2005 Dec;16(12):3687-93. Epub 2005 Nov 9.

11.

Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients.

Hartog JW, de Vries AP, Bakker SJ, Graaff R, van Son WJ, van der Heide JJ, Gans RO, Wolffenbuttel BH, de Jong PE, Smit AJ.

Nephrol Dial Transplant. 2006 Aug;21(8):2263-9. Epub 2006 Apr 5.

12.

Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.

Tanaka K, Tani Y, Asai J, Nemoto F, Kusano Y, Suzuki H, Hayashi Y, Asahi K, Nakayama M, Miyata T, Watanabe T.

Diabet Med. 2012 Apr;29(4):492-500. doi: 10.1111/j.1464-5491.2011.03448.x.

PMID:
21916970
13.

Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.

Rajaobelina K, Cougnard-Gregoire A, Delcourt C, Gin H, Barberger-Gateau P, Rigalleau V.

J Gerontol A Biol Sci Med Sci. 2015 Jul;70(7):841-6. doi: 10.1093/gerona/glu243. Epub 2015 Jan 14.

PMID:
25589479
14.

Relationship of skin autofluorescence to severity of retinopathy in type 2 diabetes.

Yasuda M, Shimura M, Kunikata H, Kanazawa H, Yasuda K, Tanaka Y, Konno H, Takahashi M, Kokubun T, Maruyama K, Sato N, Kakizaki M, Sato M, Tsuji I, Miyata T, Nakazawa T.

Curr Eye Res. 2015 Mar;40(3):338-45. doi: 10.3109/02713683.2014.918152. Epub 2014 May 28.

PMID:
24871684
15.
16.

Advanced glycation end products are associated with arterial stiffness in type 1 diabetes.

Llauradó G, Ceperuelo-Mallafré V, Vilardell C, Simó R, Gil P, Cano A, Vendrell J, González-Clemente JM.

J Endocrinol. 2014 Jun;221(3):405-13. doi: 10.1530/JOE-13-0407. Epub 2014 Mar 28.

17.

Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories.

Berger JS, Hochman J, Lobach I, Adelman MA, Riles TS, Rockman CB.

J Vasc Surg. 2013 Sep;58(3):673-81.e1. doi: 10.1016/j.jvs.2013.01.053. Epub 2013 May 2.

18.

Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.

Noordzij MJ, Mulder DJ, Oomen PH, Brouwer T, Jager J, Castro Cabezas M, Lefrandt JD, Smit AJ.

Diabet Med. 2012 Dec;29(12):1556-61. doi: 10.1111/dme.12005.

PMID:
22937960
19.

Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review.

Bos DC, de Ranitz-Greven WL, de Valk HW.

Diabetes Technol Ther. 2011 Jul;13(7):773-9. doi: 10.1089/dia.2011.0034. Epub 2011 Apr 21. Review.

PMID:
21510765
20.

Relationship of skin autofluorescence to cardiovascular disease in Japanese hemodialysis patients.

Tanaka K, Katoh T, Asai J, Nemoto F, Suzuki H, Asahi K, Sato K, Sakaue M, Miyata T, Watanabe T.

Ther Apher Dial. 2010 Jun;14(3):334-40. doi: 10.1111/j.1744-9987.2009.00782.x.

PMID:
20609188
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk